Show Summary Details
Page of

Introduction to biological and molecular psychiatry 

Introduction to biological and molecular psychiatry
Introduction to biological and molecular psychiatry

Andrew Hodgkiss

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 17 April 2021

An introduction to biological and molecular psychiatry is offered, intended for oncology and palliative medicine clinicians. A recent historical perspective is used, beginning with a summary of monoaminergic and cholinergic neurotransmission as understood in the 1980s. One endocrine theory of depression, based on HPA axis dysfunction, is described. Recognition of the limits of these models has led to a deeper molecular psychiatry ‘beyond the synapse’ and to an appreciation of the importance of amino acid neurotransmission. Selective expression of proteins, and their covalent and allosteric modification, is now seen as central to neuroplasticity. The NMDA receptor and excitotoxicity are introduced. The chapter closes with an overview of the amygdala and of hippocampal neurogenesis.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.